BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Laprovitera N, Riefolo M, Ambrosini E, Klec C, Pichler M, Ferracin M. Cancer of Unknown Primary: Challenges and Progress in Clinical Management. Cancers (Basel) 2021;13:451. [PMID: 33504059 DOI: 10.3390/cancers13030451] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Koval AP, Blagodatskikh KA, Kushlinskii NE, Shcherbo DS. The Detection of Cancer Epigenetic Traces in Cell-Free DNA. Front Oncol 2021;11:662094. [PMID: 33996585 DOI: 10.3389/fonc.2021.662094] [Reference Citation Analysis]
2 Blecua P, Davalos V, de Villasante I, Merkel A, Musulen E, Coll-SanMartin L, Esteller M. Refinement of computational identification of somatic copy number alterations using DNA methylation microarrays illustrated in cancers of unknown primary. Brief Bioinform 2022:bbac161. [PMID: 35524475 DOI: 10.1093/bib/bbac161] [Reference Citation Analysis]
3 Laprovitera N, Salamon I, Gelsomino F, Porcellini E, Riefolo M, Garonzi M, Tononi P, Valente S, Sabbioni S, Fontana F, Manaresi N, D'Errico A, Pantaleo MA, Ardizzoni A, Ferracin M. Genetic Characterization of Cancer of Unknown Primary Using Liquid Biopsy Approaches. Front Cell Dev Biol 2021;9:666156. [PMID: 34178989 DOI: 10.3389/fcell.2021.666156] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Yulian ED, Hwei LRY, Tambun R, Siswoyo AD, Ham MF, Suroyo I. Comprehensive evaluation on cancer of unknown primary site and how we managed it: A case report. Int J Surg Case Rep 2022;93:106954. [PMID: 35339815 DOI: 10.1016/j.ijscr.2022.106954] [Reference Citation Analysis]
5 Jia X, Zhao S, Li X, Lv L, Chen X, Pan E, Ou Q, Song C, Sun S, Zhao J, Xu L, Li M. Favorable Response to Olaparib in a Patient with Cancer of Unknown Primary Carrying a Germline BRCA1 R71K Mutation. Onco Targets Ther 2021;14:5353-60. [PMID: 34866915 DOI: 10.2147/OTT.S334847] [Reference Citation Analysis]
6 Zhang Y, Xia L, Ma D, Wu J, Xu X, Xu Y. 90-Gene Expression Profiling for Tissue Origin Diagnosis of Cancer of Unknown Primary. Front Oncol 2021;11:722808. [PMID: 34692498 DOI: 10.3389/fonc.2021.722808] [Reference Citation Analysis]
7 Laprovitera N, Riefolo M, Porcellini E, Durante G, Garajova I, Vasuri F, Aigelsreiter A, Dandachi N, Benvenuto G, Agostinis F, Sabbioni S, Berindan Neagoe I, Romualdi C, Ardizzoni A, Trerè D, Pichler M, D'Errico A, Ferracin M. MicroRNA expression profiling with a droplet digital PCR assay enables molecular diagnosis and prognosis of cancers of unknown primary. Mol Oncol 2021. [PMID: 34075699 DOI: 10.1002/1878-0261.13026] [Reference Citation Analysis]